Metachronous multiple esophageal squamous cell carcinomas and Lugol-voiding lesions after endoscopic mucosal resection

Y. Urabe; T. Hiyama; S. Tanaka; S. Oka; M. Yoshihara; K. Arihiro; K. Chayama

doi:10.1055/s-0029-1214477

Endoscopy, Table of Contents

Endoscopy 2009; 41(4): 304-309
DOI: 10.1055/s-0029-1214477

Original article

Metachronous multiple esophageal squamous cell carcinomas and Lugol-voiding lesions after endoscopic mucosal resection

Y. Urabe¹ , T. Hiyama² , S. Tanaka³ , S. Oka³ , M. Yoshihara² , K. Arihiro⁴ , K. Chayama¹

¹Department of Medicine and Molecular Science, Division of Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
²Health Service Center, Hiroshima University, Higashihiroshima, Japan
³Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan
⁴Department of Anatomical Pathology, Hiroshima University Hospital, Hiroshima, Japan

Abstract

Background and study aims: Endoscopic mucosal resection (EMR) has been applied to the treatment of superficial esophageal squamous cell carcinoma (SCC). The incidence and characteristics of metachronous multiple esophageal SCCs and Lugol-voiding lesions (LVLs) were investigated in a retrospective study in patients who had undergone EMR for superficial esophageal SCC.

Patients and methods: 96 patients with esophageal SCC who had been treated by EMR were followed up by endoscopy for 12 months or longer. Clinicopathologic parameters such as tumor size and location and presence of LVLs were examined.

Results: 10 patients (10 %) had synchronous multiple SCCs, and 12 (13 %) developed metachronous multiple SCCs. The mean annual incidence of newly diagnosed tumor was 4.4 %. The incidence of a speckled pattern of LVLs was 20/74 (27 %) in patients with solitary SCC, 5/10 (50 %) in synchronous multiple SCC, and 10/12 (83 %) in metachronous multiple SCC. The incidence of the presence of speckled pattern of LVLs was significantly higher in patients with multiple SCCs than in those with solitary SCC (68 % vs. 27 %, P = 0.0004).

Conclusions: Patients who have undergone EMR for esophageal SCC, especially those with metachronous multiple LVLs in the background mucosa, should undergo follow-up with close endoscopic observation using Lugol staining.

Full Text

References

1 Holmes R S, Vaughan T L. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol. 2007; 17 2-9
2 Xing D, Tan W, Lin D. Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). Oncol Rep. 2003; 10 1615-1623
3 Meyer V, Burtin P, Bour B. et al . Endoscopic detection of early esophageal cancer in a high-risk population: does Lugol staining improve videoendoscopy?. Gastrointest Endosc. 1997; 45 480-484
4 Dawsey S M, Fleischer D E, Wang G Q. et al . Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer. 1998; 83 220-231
5 Mori M, Adachi Y, Matsushima T. et al . Lugol staining pattern and histology of esophjageal lesions. Am J Gastroenterol. 1993; 88 701-705
6 Tachibana M, Kinugasa S, Shibakita M. et al . Surgical treatment of superficial esophageal cancer. Langenbecks Arch Surg. 2006; 391 304-321
7 Kanamoto A, Yamaguchi H, Nakanishi Y. et al . Clinicopathological study of multiple superficial oesophageal carcinoma. Br J Surg. 2000; 87 1712-1715
8 Katagiri A, Kaneko K, Konishi K. et al . Lugol staining pattern in background epithelium of patients with esophageal squamous cell carcinoma. Hepatogastroenterology. 2004; 51 713-717
9 Yokoyama A, Muramatsu T, Ohmori T. et al . Multiple primary esophageal and concurrent upper aerodigestive tract cancer and aldehyde dehydrogenase-2 genotype of Japanese alcoholics. Cancer. 1996; 77 1986-1990
10 Katada C, Muto M, Manabe T. et al . Local recurrence of squamous-cell carcinoma of the esophagus after EMR. Gastrointest Endosc. 2005; 61 219-225
11 Japanese Society for Esophageal Disease .Guidelines for Clinical and Pathological studies on Carcinoma of the Esophagus, 10th edn. Tokyo; Kanehara 2007
12 Warren S, Gates O. Multiple primary malignalnt tumors. A survey of the literature and a statistical study. Am J Cancer. 1932; 16 1358-1414
13 Muto M, Hirohata S, Nakane M. et al . Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc. 2002; 56 517-521
14 Shimizu Y, Tukagoshi H, Fujita M. et al . Metachronous squamous cell carcinoma of the esophagus arising after endoscopic mucosal resection. Gastrointest Endosc. 2001; 54 190-194
15 Katada C, Muto M, Manabe T. et al . Local recurrence of squamous-cell carcinoma of the esophagus after EMR. Gastrointest Endosc. 2005; 61 219-225
16 Muto M, Hitomi Y, Ohtsu A. et al . Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patients. Gut. 2000; 47 256-261
17 Kuwano H, Ohno S, Matsuda H. et al . Serial histologic evaluation of multiple primary squamous cell carcinomas of the esophagus. Cancer. 1988; 61 1635-1638
18 Shimizu Y, Tukagoshi H, Fujita M. et al . Endoscopic screening for early esophageal cancer by iodine staining in patients with other current or prior primary cancers. Gastrointest Endosc. 2001; 53 1-5
19 Dubuc J, Legoux J L, Winnock M. et al . Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers. Endoscopy. 2006; 38 690-695
20 Muto M, Takahashi M, Ohtsu A. et al . Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region. Carcinogenesis. 2005; 26 1008-1012
21 Slaughter D P, Southwick H W, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1998; 82 1454-1459
22 Ishii T, Murakami J, Natohara K. et al . Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa. Gut. 2007; 56 13-19
23 Hiyama T, Yoshihara M, Tanaka S. et al . Genetic polymorphisms and esophageal cancer risk. Int J Cancer. 2007; 121 1643-1658
24 Lewis S J, Smith G D. Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev. 2005; 14 1967-1971
25 Yang C X, Matsuo K, Wang Z M. et al . Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature. World J Gastroenterol. 2005; 11 2531-2538
26 Zeka A, Gore R, Kriebel D. Effects of alcohol and tobacco on aerodigestive cancer risks: a meta-regression analysis. Cancer Causes Control. 2003; 14 897-906
27 Kondo H, Fukuda H, Ono H. et al . Sodium thiosulfate solution spray for relief of irritation caused by Lugol’s stain in chromoendoscopy. Gastrointest Endosc. 2001; 53 199-202
28 Park J M, Lee I S, Kang J Y. et al . Acute esophageal and gastric injury: complication of Lugol’s solution. Scand J Gastroentrol. 2007; 42 135-137
29 Inoue H, Sasajima K, Kaga M. et al . Endoscopic in vivo evaluation of tissue atypia in the esophagus using a newly designed integrated endocytoscope: a pilot trial. Endoscopy. 2006; 38 891-895
30 Yoshida T, Inoue H, Usui S. et al . Narrow-band imaging system with magnifying endoscopy for superficial esophageal lesions. Gastrointest Endosc. 2004; 59 288-295
31 Hirata M, Tanaka S, Oka S. et al . Magnifying endoscopy with narrow band imaging for diagnosis of colorectal tumors. Gastrointest Endosc. 2007; 65 988-995
32 Hirata M, Tanaka S, Oka S. et al . Evaluation of microvessels in colorectal tumors by narrow band imaging magnification. Gastrointest Endosc. 2007; 66 945-952
33 Katada C, Nakayama M, Tanabe S. et al . Narrow band imaging for detecting superficial oral squamous cell carcinoma: a report of two cases. Laryngoscope. 2007; 117 1596-1599
34 Morita M, Kuwano H, Ohno S. et al . Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history. Int J Cancer. 1994; 58 207-210

T. HiyamaMD, PhD

Health Service Center
Hiroshima University

1–7-1 Kagamiyama
Higashihiroshima 739–8521
Japan

Fax: +81-82-4227156

Email: tohiyama@hiroshima-u.ac.jp